Corteria Pharmaceuticals

Recent Finacing

Series A

Recent Raise

$69.6M

Corteria Pharmaceuticals is a biopharmaceutical company that develops first-in-class therapies for unaddressed heart failure subpopulations, with a focus on multi-organ benefits targeting the kidneys, heart, and vessels.